Tai H and Zhang Z |
A novel compound heterozygous mutation in a Chinese boy with L-2-hydroxyglutaric aciduria: a case study. |
2015 |
BMC Neurol |
pmid:26208971
|
Fu X et al. |
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling. |
2015 |
Cell Metab. |
pmid:26190651
|
Hwang VJ et al. |
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:26155843
|
Macaulay RJ |
Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas. |
2015 |
Cancer Control |
pmid:26068765
|
Suijker J et al. |
The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo. |
2015 |
Oncotarget |
pmid:26046462
|
Izquierdo-Garcia JL et al. |
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. |
2015 |
Cancer Res. |
pmid:26045167
|
Pichumani K et al. |
Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas. |
2015 |
Anal. Biochem. |
pmid:25908561
|
Lombardi G et al. |
Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma. |
2015 |
Oncologist |
pmid:25862748
|
Pellegatta S et al. |
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma. |
2015 |
Acta Neuropathol Commun |
pmid:25849072
|
Ma S et al. |
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth. |
2015 |
Oncotarget |
pmid:25825982
|